Back to Search
Start Over
Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia
- Source :
- HemaSphere, Vol 2, Iss 1 (2018), HemaSphere, HemaSphere, 2018, 2 (1), pp.e29. ⟨10.1097/HS9.0000000000000029⟩, HemaSphere, Lippincott, Williams & Wilkins, 2018, 2 (1), pp.e29. ⟨10.1097/HS9.0000000000000029⟩
- Publication Year :
- 2018
- Publisher :
- Wolters Kluwer, 2018.
-
Abstract
- International audience
- Subjects :
- 0301 basic medicine
business.industry
Essential thrombocythemia
lcsh:RC633-647.5
Myeloid leukemia
Case Report
[SDV.CAN]Life Sciences [q-bio]/Cancer
Hematology
lcsh:Diseases of the blood and blood-forming organs
medicine.disease
Imatinib treatment
3. Good health
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Text mining
[SDV.CAN] Life Sciences [q-bio]/Cancer
030220 oncology & carcinogenesis
Cancer research
Medicine
business
ComputingMilieux_MISCELLANEOUS
Subjects
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 2
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- HemaSphere
- Accession number :
- edsair.doi.dedup.....95ea9d2af89e4deb1bb70093c3e13db3
- Full Text :
- https://doi.org/10.1097/HS9.0000000000000029